We are live on ! Find out more
ZSPH

ZS PHARMA INC COMS TK (DE)
ZSPH

Delisted

ZSPH was delisted on the 16th of December, 2015.

65 hedge funds and large institutions have $293M invested in ZS PHARMA INC COMS TK (DE) in 2014 Q3 according to their latest regulatory filings, with 57 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1,532% more capital invested

Capital invested by funds: $18M → $293M (+$275M)

713% more funds holding

Funds holding: 865 (+57)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

Holders
65
Holders Change
+57
Holders Change %
+712.5%
% of All Funds
1.89%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
57
Increased
3
Reduced
4
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$1.95M +$1.65M +49,817 New
NIP
27
Nicholas Investment Partners
California
$1.85M +$1.56M +47,054 New
HCMT
28
Highland Capital Management (Texas)
Texas
$1.46M +$1.23M +37,134 New
EI
29
EAM Investors
California
$1.31M +$1.1M +33,409 New
MCM
30
Mazama Capital Management
Oregon
$1.25M +$967K +29,261 +1,139%
ACM
31
Atika Capital Management
New York
$1.22M +$1.02M +31,000 New
Ameriprise
32
Ameriprise
Minnesota
$1.05M +$884K +26,734 New
U
33
UBS
Switzerland
$1.04M +$875K +26,467 New
Geode Capital Management
34
Geode Capital Management
Massachusetts
$978K +$825K +24,948 New
Alyeska Investment Group
35
Alyeska Investment Group
Illinois
$939K -$2.9M -87,742 -79%
PAM
36
Panagora Asset Management
Massachusetts
$913K +$769K +23,264 New
RFC
37
Russell Frank Company
Washington
$854K +$719K +21,764 New
PI
38
Putnam Investments
Massachusetts
$837K +$705K +21,335 New
GGHC
39
Gilder Gagnon Howe & Co
New York
$819K -$242K -7,337 -26%
TCIM
40
TIAA CREF Investment Management
New York
$819K +$690K +20,889 New
SFM
41
Sphera Funds Management
Israel
$811K +$684K +20,682 New
BIM
42
BlackRock Investment Management
Delaware
$726K +$612K +18,507 New
SIM
43
Spark Investment Management
New York
$718K +$608K +18,400 New
PIM
44
Partner Investment Management
California
$655K +$552K +16,708 New
Northern Trust
45
Northern Trust
Illinois
$598K +$504K +15,246 New
Citadel Advisors
46
Citadel Advisors
Florida
$554K -$121K -3,664 -21%
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$518K +$436K +13,200 New
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$494K +$416K +12,600 New
QSS
49
Quantitative Systematic Strategies
Florida
$357K +$299K +9,047 New
TA
50
Teachers Advisors
New York
$342K +$288K +8,709 New

ZSPH Hedge Fund Activity: Q3 2014 in Review

65 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in ZS PHARMA INC COMS TK (DE) (ZSPH) for Q3 2014, worth a combined $293M — up 1,532% from $18M a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new ZSPH positions and 0 closed out — a net gain of 57 holders — while 3 added to existing stakes and 4 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $41.7M. The largest seller was Alyeska Investment Group, cutting an estimated $2.9M.

  • 65 institutional investors held ZS PHARMA INC COMS TK (DE) (ZSPH) as of Q3 2014, up from 8 in Q2 2014.
  • Funds reported $293M of ZS PHARMA INC COMS TK (DE) stock for Q3 2014, up 1,532% quarter-over-quarter.
  • 57 funds opened new ZS PHARMA INC COMS TK (DE) positions in Q3 2014 and 0 closed out, a net change of +57 holders.
  • The largest ZS PHARMA INC COMS TK (DE) buyer in Q3 2014 was Fidelity Investments, an estimated $41.7M added.
  • The largest ZS PHARMA INC COMS TK (DE) seller in Q3 2014 was Alyeska Investment Group, an estimated $2.9M sold.

Based on aggregated 13F filings for Q3 2014.